Q3 2020 Holdings
Filed 2020-11-13 | 204 holdings | $346.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $76.6M | 874,720 | 22.1% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $60.6M | 213,753 | 17.5% |
| Boston Scientific Corp.(BSX) | Common | 101137107 | $28.3M | 741,296 | 8.2% |
| Centene Corp.(CNC) | Common | 15135B101 | $26.7M | 458,313 | 7.7% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $25.5M | 174,894 | 7.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $24.8M | 325,822 | 7.2% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $19.4M | 125,746 | 5.6% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $16.2M | 61,687 | 4.7% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $10.3M | 250,743 | 3.0% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $8.1M | 28,280 | 2.3% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $7.0M | 30,754 | 2.0% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $6.5M | 186,964 | 1.9% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $4.4M | 300,611 | 1.3% |
| Acadia Healthcare Co., Inc.(ACHC) | Common | 00404A109 | $3.9M | 131,200 | 1.1% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $3.7M | 203,103 | 1.1% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $3.3M | 10,041 | 0.9% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $3.2M | 74,186 | 0.9% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $3.2M | 607,698 | 0.9% |
| BioNTech SE(BNTX) | Sponsored ADS | 09075V102 | $3.0M | 43,595 | 0.9% |
| Axsome Therapeutics, Inc.(AXSM) | Common | 05464T104 | $2.3M | 31,591 | 0.6% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $2.0M | 110,147 | 0.6% |
| Bausch Health Companies Inc.(BHC) | Common | 071734107 | $1.8M | 118,412 | 0.5% |
| Addus HomeCare Corp.(ADUS) | Common | 006739106 | $1.5M | 15,969 | 0.4% |
| Adaptive Biotechnologies Corp.(ADPT) | Common | 00650F109 | $1.2M | 24,715 | 0.3% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $497.0K | 117,735 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $154.6K | 608,218 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $116.1K | 207,388 | 0.0% |
| Vertex Pharmaceuticals Inc.(VRTX) | Common | 92532F100 | $109.2K | 401,360 | 0.0% |
| Celldex Therapeutics, Inc.(CLDX) | Common | 15117B202 | $105.0K | 7,053 | 0.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $103.9K | 1,643,683 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $87.7K | 1,056,706 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $86.9K | 281,054 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $81.4K | 546,805 | 0.0% |
| Seagen Inc. | Common | 812578102 | $66.0K | 337,204 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $62.2K | 1,695,768 | 0.0% |
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $57.9K | 185,735 | 0.0% |
| Bristol Myers Squibb Co.(BMY) | Common | 110122108 | $57.0K | 945,140 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $55.6K | 534,914 | 0.0% |
| Horizon Therapeutics plc | Shares | G46188101 | $46.9K | 603,684 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $40.2K | 369,573 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $35.6K | 86,007 | 0.0% |
| Stryker Corp.(SYK) | Common | 863667101 | $32.9K | 157,830 | 0.0% |
| Moderna, Inc.(MRNA) | Common | 60770K107 | $32.6K | 460,359 | 0.0% |
| Becton, Dickinson and Co.(BDX) | Common | 075887109 | $30.6K | 131,723 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $30.5K | 266,791 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $29.0K | 206,487 | 0.0% |
| Exelixis, Inc.(EXEL) | Common | 30161Q104 | $26.8K | 1,095,117 | 0.0% |
| Eli Lilly and Co.(LLY) | Common | 532457108 | $26.3K | 177,637 | 0.0% |
| Zimmer Biomet Holdings, Inc.(ZBH) | Common | 98956P102 | $26.1K | 191,937 | 0.0% |
| Edwards Lifesciences Corp.(EW) | Common | 28176E108 | $23.2K | 291,155 | 0.0% |